Sensei biotherapeutics to participate in the 32nd annual oppenheimer healthcare conference

Boston, march 03, 2022 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that company management will participate in the 32 nd annual oppenheimer healthcare conference, taking place virtually march 15-17, 2022.

SNSE Ratings Summary

SNSE Quant Ranking